PHLDB3

Model summary

A human membrane-proximal scaffold that uses a C-terminal pleckstrin-homology module to anchor soluble signaling assemblies at the cytoplasmic face of the plasma membrane. By binding and organizing enzymes and adaptors, it modulates adhesion-dependent signaling pathways that feed into epidermal tissue programs. Its dynamic partitioning between membrane, cytosol, and nucleoplasm enables coordinated control of adhesion, cytoskeletal linkage, and gene-regulatory outputs during epidermal development and maintenance.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The C-terminal half of the protein is dominated by a pleckstrin-homology module: IPR011993 (PH-like domain superfamily, residues 530–638) encompasses IPR001849 (Pleckstrin homology domain, residues 532–637) and the lineage-specific IPR037810 (PHLDB1/2/3, PH domain, residues 535–635). This tandem of a canonical PH fold nested within a PH-like superfamily, and reinforced by a PHLDB-specific PH signature, establishes a membrane-targeting module that binds phosphoinositides and recruits signaling assemblies at the cytoplasmic face of membranes. The broader family context IPR052212 (Pleckstrin homology-like domain-containing protein, residues 497–639) extends this inference N-terminally and functionally, indicating a scaffold that uses lipid-anchored positioning to organize protein complexes. The ordered layout—an extended region culminating in a high-confidence PH core—causes peripheral membrane association and soluble cytosolic/nuclear pools, consistent with dynamic shuttling between compartments.

2. 02

   From this architecture, the molecular function resolves as enzyme-binding scaffolding.

   PH domains frequently nucleate complexes by docking kinases, lipid phosphatases, and cytoskeletal regulators at membrane microdomains. The presence of a lineage-tuned PH domain (IPR037810) argues that the module selects specific phosphoinositide species and adaptor surfaces, which in turn stabilizes enzyme-rich assemblies. This supports GO:0019899 enzyme binding as the operative molecular function: the PH core positions and binds enzymatic partners to regulate pathway flux rather than catalyzing reactions itself.

3. 03

   The biological process follows from how such scaffolds govern cell-surface signaling and adhesion programs that feed into tissue morphogenesis.

   By concentrating signaling enzymes and adhesion machinery at the membrane and coupling them to cytoskeletal and transcriptional pathways, this architecture drives programs that shape stratified epithelia. This causal chain—membrane-tethered enzyme-binding scaffold regulating adhesion and signaling—maps to GO:0008544 epidermis development, where precise control of adhesion and barrier formation is essential.

4. 04

   Cellular localization is dictated by the PH-driven membrane affinity and soluble reservoirs.

   The PH module targets the cytoplasmic leaflet of the plasma membrane, explaining GO:0005886 plasma membrane and the experimentally observed peripheral membrane behavior. The soluble pool and nuclear shuttling of many PH-containing scaffolds rationalize GO:0005829 cytosol and GO:0005654 nucleoplasm. Together, these compartments reflect a dynamic cycle: membrane recruitment, cytosolic transit, and occasional nuclear entry to coordinate gene-expression programs downstream of adhesion and signaling cues.

5. 05

   Mechanistically, I hypothesize that the protein operates as a membrane-proximal scaffold that binds phosphoinositides via its PH domain to assemble enzyme-rich complexes controlling adhesion and differentiation pathways central to epidermal biology.

   Likely partners include membrane-associated kinases and adaptors that tune cytoskeletal attachment and signaling thresholds. By stabilizing these assemblies at the plasma membrane and coordinating their soluble phases in the cytosol and nucleoplasm, the protein modulates adhesion-dependent signaling cascades that culminate in epidermal tissue development and maintenance.